Bortezomib in multiple myeloma.
D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D018450:Disease Progression; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D010266:Paraproteins / Q000032:analysis; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*
D001897:Boronic Acids; D010266:Paraproteins; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib